Finance

Lists
Why is NH down 2.65%?
Dive Deeper
NH:NSE
Narayana Hrudayalaya Ltd
₹1,744.00
-2.65%
(-47.40) 1D
Oct 1, 3:30:02 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NH...
Open
₹1,774.90
High
₹1,774.90
Low
₹1,714.10
Mkt. cap
354.21B
Avg. vol.
242.08K
Volume
258.74K
Dividend
0.26%
Quarterly dividend
₹1.12
Ex-dividend date
Jul 17, 2026
P/E ratio
43.36
52-wk high
₹2,093.30
52-wk low
₹1,589.00
EPS
₹40.22
Shares outstanding
204.36M
No. of employees
11K
Open
₹1,774.90
High
₹1,774.90
Low
₹1,714.10
Mkt. cap
354.21B
Avg. vol.
242.08K
Volume
258.74K
Dividend
0.26%
Quarterly dividend
₹1.12
Ex-dividend date
Jul 17, 2026
P/E ratio
43.36
52-wk high
₹2,093.30
52-wk low
₹1,589.00
EPS
₹40.22
Shares outstanding
204.36M
No. of employees
11K
News stories
From web sources and news partners
Profile
Narayana Health is an Indian for-profit private hospital network headquartered in Bangalore. It was founded by Dr. Devi Shetty in the year 2000. It operates several hospitals and heart centres across major Indian cities Bangalore, Delhi, Gurugram, Kolkata, Ahmedabad, Raipur, Jaipur, Mumbai, Mysore etc. with an international subsidiary in the Cayman Islands. The facilities offer medical care in over 30 medical specialties and three of its hospitals – Narayana Institute of Cardiac Sciences, Bangalore, and Health City Cayman Islands – are JCI accredited. Wikipedia
About Narayana Hrudayalaya Ltd
CEOEmmanuel Rupert
Employees11.2K
Founded2000
HeadquartersBengaluru, Karnataka, India
SectorHealth care provider
Websitenarayanahealth.org
Last report
Aug 3, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹10.20 / ₹11.93
-14.53%miss
Revenue / Est. (INR)
26.84B / 26.38B
+1.74%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
16.44B
21.51B
25.94B
26.84B
Cost of goods sold
8.76B
11.99B
18.24B
15.66B
Cost of revenue
8.76B
11.99B
18.24B
15.66B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
2.56B
-
Operating expense
4.53B
7.07B
4.14B
8.04B
Total operating expenses
13.29B
19.06B
22.38B
23.70B
Operating income
3.15B
2.45B
3.56B
3.14B
Other non operating income
239.92M
232.06M
-498.95M
354.76M
EBT including unusual items
2.95B
1.50B
2.92B
2.60B
EBT excluding unusual items
2.95B
2.01B
2.80B
2.60B
Income tax expense
371.93M
222.70M
641.07M
531.19M
Effective tax rate
12.59%
14.81%
21.94%
20.40%
Other operating expenses
3.65B
5.85B
38.10M
6.48B
Net income
2.58B
1.27B
2.24B
2.07B
Net profit margin
15.72%
5.89%
8.63%
7.72%
Earnings per share
12.71
8.45
11.22
10.20
Interest and investment income
-
-
594.31M
-
Interest expense
-422.60M
-650.33M
-912.85M
-868.01M
Net interest expenses
-422.60M
-650.33M
-318.54M
-868.01M
Depreciation and amortization charges
874.76M
1.22B
1.54B
1.56B
EBITDA
4.01B
3.01B
4.45B
4.03B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps